• Exemptia

    World’s first Adalimumab biosimilar with FINGERPRINT match

  • Ankylosing Spondylitis

Biosimilarity between Exemptia and
Originator Adalimumab

Read More

Comparison of Safety and efficacy of Exemptia and Originator Adalimumab in Patients with Rheumatoid Arthritis

Read More